Literature DB >> 34105987

Human Urine Alters Methicillin-Resistant Staphylococcus aureus Virulence and Transcriptome.

Santosh Paudel1, Kamal Bagale1, Swapnil Patel1, Nicholas J Kooyers1, Ritwij Kulkarni1.   

Abstract

Gram-positive methicillin-resistant Staphylococcus aureus (MRSA) is an emerging cause of hospital-associated urinary tract infections (UTI), especially in catheterized individuals. Despite being rare, MRSA UTI are prone to potentially life-threatening exacerbations such as bacteremia that can be refractory to routine antibiotic therapy. To delineate the molecular mechanisms governing MRSA urinary pathogenesis, we exposed three S. aureus clinical isolates, including two MRSA strains, to human urine for 2 h and analyzed virulence characteristics and changes in gene expression. The in vitro virulence assays showed that human urine rapidly alters adherence to human bladder epithelial cells and fibronectin, hemolysis of sheep red blood cells (RBCs), and surface hydrophobicity in a staphylococcal strain-specific manner. In addition, transcriptome sequencing (RNA-Seq) analysis of uropathogenic strain MRSA-1369 revealed that 2-h-long exposure to human urine alters MRSA transcriptome by modifying expression of genes encoding enzymes catalyzing metabolic pathways, virulence factors, and transcriptional regulators. In summary, our results provide important insights into how human urine specifically and rapidly alters MRSA physiology and facilitates MRSA survival in the nutrient-limiting and hostile urinary microenvironment. IMPORTANCE Methicillin-resistant Staphylococcus aureus (MRSA) is an uncommon cause of urinary tract infections (UTI) in the general population. However, it is important to understand MRSA pathophysiology in the urinary tract because isolation of MRSA in urine samples often precedes potentially life-threatening MRSA bacteremia. In this report, we describe how exposure to human urine alters MRSA global gene expression and virulence. We hypothesize that these alterations may aid MRSA in acclimating to the nutrient-limiting, immunologically hostile conditions within the urinary tract leading to MRSA UTI.

Entities:  

Keywords:  MRSA; RNA-Seq; Staphylococcus aureus; UTI; transcriptome analysis; urinary tract infection; virulence

Mesh:

Substances:

Year:  2021        PMID: 34105987      PMCID: PMC8315183          DOI: 10.1128/AEM.00744-21

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  44 in total

1.  Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus.

Authors:  Christof von Eiff; Alexander W Friedrich; Georg Peters; Karsten Becker
Journal:  Diagn Microbiol Infect Dis       Date:  2004-07       Impact factor: 2.803

2.  Incidence and Outcomes of Staphylococcus aureus Bacteriuria: A Population-based Study.

Authors:  William Stokes; Michael D Parkins; Elizabeth C T Parfitt; Juan C Ruiz; Gerry Mugford; Daniel B Gregson
Journal:  Clin Infect Dis       Date:  2019-08-30       Impact factor: 9.079

3.  Cigarette smoke increases Staphylococcus aureus biofilm formation via oxidative stress.

Authors:  Ritwij Kulkarni; Swati Antala; Alice Wang; Fábio E Amaral; Ryan Rampersaud; Samuel J Larussa; Paul J Planet; Adam J Ratner
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

Review 4.  Community-associated MRSA: what makes them special?

Authors:  Michael Otto
Journal:  Int J Med Microbiol       Date:  2013-03-19       Impact factor: 3.473

5.  Discovery and Characterization of Human-Urine Utilization by Asymptomatic-Bacteriuria-Causing Streptococcus agalactiae.

Authors:  Deepak S Ipe; Nouri L Ben Zakour; Matthew J Sullivan; Scott A Beatson; Kimberly B Ulett; William H Benjamin; Mark R Davies; Samantha J Dando; Nathan P King; Allan W Cripps; Mark A Schembri; Gordon Dougan; Glen C Ulett
Journal:  Infect Immun       Date:  2015-11-09       Impact factor: 3.441

6.  Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis.

Authors:  I M Nilsson; O Hartford; T Foster; A Tarkowski
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

7.  Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation in the human nose.

Authors:  Bernhard Krismer; Manuel Liebeke; Daniela Janek; Mulugeta Nega; Maren Rautenberg; Gabriele Hornig; Clemens Unger; Christopher Weidenmaier; Michael Lalk; Andreas Peschel
Journal:  PLoS Pathog       Date:  2014-01-16       Impact factor: 6.823

8.  Antibody-Based Therapy for Enterococcal Catheter-Associated Urinary Tract Infections.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Aaron Potretzke; Henry L Schreiber; Jerome S Pinkner; Tyler M Bauman; Alyssa M Park; Alana Desai; Scott J Hultgren; Michael G Caparon
Journal:  mBio       Date:  2016-10-25       Impact factor: 7.867

9.  UniProt: a worldwide hub of protein knowledge.

Authors: 
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

10.  The Staphylococcus aureus ArlRS two-component system is a novel regulator of agglutination and pathogenesis.

Authors:  Jennifer N Walker; Heidi A Crosby; Adam R Spaulding; Wilmara Salgado-Pabón; Cheryl L Malone; Carolyn B Rosenthal; Patrick M Schlievert; Jeffrey M Boyd; Alexander R Horswill
Journal:  PLoS Pathog       Date:  2013-12-19       Impact factor: 6.823

View more
  2 in total

1.  Preferential catabolism of l- vs d-serine by Proteus mirabilis contributes to pathogenesis and catheter-associated urinary tract infection.

Authors:  Aimee L Brauer; Brian S Learman; Steven M Taddei; Namrata Deka; Benjamin C Hunt; Chelsie E Armbruster
Journal:  Mol Microbiol       Date:  2022-08-15       Impact factor: 3.979

2.  Copper Resistance Promotes Fitness of Methicillin-Resistant Staphylococcus aureus during Urinary Tract Infection.

Authors:  Panatda Saenkham-Huntsinger; Amanda N Hyre; Braden S Hanson; George L Donati; L Garry Adams; Chanelle Ryan; Alejandra Londoño; Ahmed M Moustafa; Paul J Planet; Sargurunathan Subashchandrabose
Journal:  mBio       Date:  2021-09-07       Impact factor: 7.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.